Patients diagnosed with MDD have elevated systemic levels of enzymes involved in the production of reactive oxygen species (ROS) and reactive nitrogen species (RNS) compared to healthy controls,8,9,11 leading to an increase in the levels of xanthine oxidase and ROS in the blood and brain of MDD patients. The gene discussed is XDH; the disease is major depressive disorder.